120 related articles for article (PubMed ID: 38775730)
1. miR-101a-3p/ROCK2 axis regulates neuronal injury in Parkinson's disease models.
Tao X; Zhang W; Chen C; Tao Y; Tao Y; Chen Z; Zhang G
Aging (Albany NY); 2024 May; 16(10):8732-8746. PubMed ID: 38775730
[TBL] [Abstract][Full Text] [Related]
2. SNHG14 Elevates NFAT5 Expression Through Sequestering miR-375-3p to Promote MPP + -Induced Neuronal Apoptosis, Inflammation, and Oxidative Stress in Parkinson's Disease.
Xu F; Bian N; Li X
Neurochem Res; 2024 May; 49(5):1212-1225. PubMed ID: 38381247
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOTAIR promotes α-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating miR-221-3p in Parkinson's disease.
Sun Q; Zhang Y; Wang S; Yang F; Cai H; Xing Y; Zhou L; Chen S; Wang Y
Exp Cell Res; 2022 Aug; 417(1):113132. PubMed ID: 35398161
[TBL] [Abstract][Full Text] [Related]
4. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2
Lang Y; Li Y; Yu H; Lin L; Chen X; Wang S; Zhang H
Aging (Albany NY); 2020 May; 12(9):7660-7678. PubMed ID: 32396526
[TBL] [Abstract][Full Text] [Related]
5. SNHG1 promotes MPP
Zhao J; Geng L; Chen Y; Wu C
Biol Res; 2020 Jan; 53(1):1. PubMed ID: 31907031
[TBL] [Abstract][Full Text] [Related]
6. Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.
Su C; Yang X; Lou J
Brain Res; 2016 Aug; 1644():98-106. PubMed ID: 27173998
[TBL] [Abstract][Full Text] [Related]
7. Berberine Attenuates MPP
Li X; Su Y; Li N; Zhang FR; Zhang N
Neurochem Res; 2021 Dec; 46(12):3286-3300. PubMed ID: 34427876
[TBL] [Abstract][Full Text] [Related]
8. Mir-141-3p Regulates Apoptosis and Mitochondrial Membrane Potential via Targeting Sirtuin1 in a 1-Methyl-4-Phenylpyridinium in vitro Model of Parkinson's Disease.
Zheng Y; Dong L; Liu N; Luo X; He Z
Biomed Res Int; 2020; 2020():7239895. PubMed ID: 33204711
[TBL] [Abstract][Full Text] [Related]
9. LINC00943 acts as miR-338-3p sponge to promote MPP
Sun X; Zhang C; Tao H; Yao S; Wu X
Brain Res; 2022 May; 1782():147814. PubMed ID: 35123924
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA myocardial infarction-associated transcript promotes 1-Methyl-4-phenylpyridinium ion-induced neuronal inflammation and oxidative stress in Parkinson's disease through regulating microRNA-221-3p/ transforming growth factor /nuclear factor E2-related factor 2 axis.
Lang Y; Zhang H; Yu H; Li Y; Liu X; Li M
Bioengineered; 2022 Jan; 13(1):930-940. PubMed ID: 34967706
[TBL] [Abstract][Full Text] [Related]
11. SOS1-IT1 silencing alleviates MPP
Fan J; Wu D; Guo Y; Yang Z
J Clin Neurosci; 2022 May; 99():137-146. PubMed ID: 35279586
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
13. Regulatory Mechanism of miR-543-3p on GLT-1 in a Mouse Model of Parkinson's Disease.
Wu X; Meng X; Tan F; Jiao Z; Zhang X; Tong H; He X; Luo X; Xu P; Qu S
ACS Chem Neurosci; 2019 Mar; 10(3):1791-1800. PubMed ID: 30676715
[TBL] [Abstract][Full Text] [Related]
14. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NEAT1 Regulates the Development of Parkinson's Disease by Targeting AXIN1 Via Sponging miR-212-3p.
Liu T; Zhang Y; Liu W; Zhao J
Neurochem Res; 2021 Feb; 46(2):230-240. PubMed ID: 33241432
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG15 mediates 1-methyl-4-phenylpyridinium (MPP
Li J; Sun Z; Song L
Neurol Res; 2023 Feb; 45(2):181-190. PubMed ID: 36384413
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective microRNA-381 Binds to Repressed Early Growth Response 1 (EGR1) and Alleviates Oxidative Stress Injury in Parkinson's Disease.
Guo S; Gao Y; Zhao Y
ACS Chem Neurosci; 2023 Jun; 14(11):1981-1991. PubMed ID: 37166273
[TBL] [Abstract][Full Text] [Related]
18. LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p/alpha-synuclein axis in Parkinson's disease.
Zhang J; Yang Y; Zhou C; Zhu R; Xiao X; Zhou B; Wan D
Bioengineered; 2022 Feb; 13(2):4493-4516. PubMed ID: 35137671
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.
Park JS; Choe K; Lee HJ; Park TJ; Kim MO
J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205
[TBL] [Abstract][Full Text] [Related]
20. MALAT1 Mediates
Geng X; Zou Y; Li S; Qi R; Yu H; Li J
Mediators Inflamm; 2023; 2023():4477492. PubMed ID: 37064502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
